(Q45919154)

English

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.

scientific article published in October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. (English)

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

chemoradiotherapy

0 references

author name string

Robert Haddad

1

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Stephen Sonis

2

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Marshall Posner

3

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Lori Wirth

4

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Rosemary Costello

5

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Patricia Braschayko

6

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Aaron Allen

7

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Anand Mahadevan

8

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Jayme Flynn

9

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Elaine Burke

10

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Yi Li

11

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Roy B Tishler

12

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

language of work or name

0 references

publication date

1 October 2009

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

115

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

19

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

4514-4523

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

21 January 2018

Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

21 January 2018

Recent advances in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Dysphagia after chemoradiation: prevention and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of cytokines (TNF-α, IL-1β and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Blockage of tumor necrosis factor prevents intestinal mucosal inflammation through down-regulation of interleukin-23 secretion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24525

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24525

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

1 reference

Europe PubMed Central

17 December 2017

http://europepmc.org/abstract/MED/19634161

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45919154&oldid=1424892218"